Comparative effectiveness analysis of Pipeline device versus coiling in unruptured aneurysms smaller than 10 mm

Restricted access

OBJECTIVE

Both endovascular coiling and the Pipeline embolization device (PED) have been shown to be safe and clinically effective for treatment of small (< 10 mm) aneurysms. The authors conducted a comparative effectiveness analysis to compare the utility of these treatment methods in terms of health benefits.

METHODS

A decision-analytical study was performed with Markov modeling methods to simulate patients with small unruptured aneurysms undergoing endovascular coiling, stent-assisted coiling (SAC), or PED placement for treatment. Input probabilities were derived from prior literature, and 1-way, 2-way, and probabilistic sensitivity analyses were performed to assess model and input parameter uncertainty.

RESULTS

The base case calculation for a 50-year-old man reveals PED to have a higher health benefit (17.48 quality-adjusted life years [QALYs]) than coiling (17.44 QALYs) or SAC (17.36 QALYs). PED is the better option in 6020 of the 10,000 iterations in probabilistic sensitivity analysis. When the retreatment rate of PED is lower than 9.53%, and the coiling retreatment is higher than 15.6%, PED is the better strategy. In the 2-way sensitivity analysis varying the retreatment rates from both treatment modalities, when the retreatment rate of PED is approximately 14% lower than the retreatment rate of coiling, PED is the more favorable treatment strategy. Otherwise, coiling is more effective. SAC may be better than PED when the unfavorable outcome risk of SAC is lower than 70% of its reported current value.

CONCLUSIONS

With the increasing use of PEDs for treatment of small unruptured aneurysms, the current study indicates that these devices may have higher health benefits due to lower rates of retreatment compared to both simple coiling and stent-assisted techniques. Longer follow-up studies are needed to document the rates of recurrence and retreatment after coiling and PED to assess the cost-effectiveness of these strategies.

ABBREVIATIONS IntrePED = International Retrospective Study of Pipeline Embolization Device; mRS = modified Rankin Scale; PED = Pipeline embolization device; QALYs = quality-adjusted life years; SAC = stent-assisted coiling; UIA = unruptured intracranial aneurysm.

Article Information

Correspondence Ajay Malhotra: Yale School of Medicine, New Haven, CT. ajay.malhotra@yale.edu.

INCLUDE WHEN CITING Published online January 11, 2019; DOI: 10.3171/2018.8.JNS181080.

A.M. and X.W. contributed equally to this work and share first authorship.

Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Simplified decision tree structure.

  • View in gallery

    Bar graph showing distributions of probabilistic sensitivity analysis. Trials lying to the right of zero are those in which PED is the better strategy. EV = endovascular.

  • View in gallery

    Upper: One-way sensitivity analysis varying the retreatment rate of coiling. A higher health benefit is more desirable. Lower: One-way sensitivity analysis varying the retreatment rate of PED. A higher health benefit is more desirable.

  • View in gallery

    Upper: Two-way sensitivity analysis varying retreatment rates of PED and coiling. The color indicates area where the corresponding strategy is preferred. Lower: Two-way sensitivity analysis varying retreatment rates of PED and SAC. The color indicates area where the corresponding strategy is preferred.

References

1

Becske TBrinjikji WPotts MBKallmes DFShapiro MMoran CJ: Long-term clinical and angiographic outcomes following Pipeline Embolization Device treatment of complex internal carotid artery aneurysms: five-year results of the Pipeline for Uncoilable or Failed Aneurysms trial. Neurosurgery 80:40482017

2

Briganti FNapoli MLeone GMarseglia MMariniello GCaranci F: Treatment of intracranial aneurysms by flow diverter devices: long-term results from a single center. Eur J Radiol 83:168316902014

3

Brinjikji WKallmes DFCloft HJLanzino G: Age-related outcomes following intracranial aneurysm treatment with the Pipeline Embolization Device: a subgroup analysis of the IntrePED registry. J Neurosurg 124:172617302016

4

Brinjikji WMurad MHLanzino GCloft HJKallmes DF: Endovascular treatment of intracranial aneurysms with flow diverters: a meta-analysis. Stroke 44:4424472013

5

Chalouhi NDaou BBarros GStarke RMChitale AGhobrial G: Matched comparison of flow diversion and coiling in small, noncomplex intracranial aneurysms. Neurosurgery 81:92972017

6

Chalouhi NMcMahon JFMoukarzel LAStarke RMJabbour PDumont AS: Flow diversion versus traditional aneurysm embolization strategies: analysis of fluoroscopy and procedure times. J Neurointerv Surg 6:2912952014

7

Chalouhi NZanaty MWhiting AYang STjoumakaris SHasan D: Safety and efficacy of the Pipeline Embolization Device in 100 small intracranial aneurysms. J Neurosurg 122:149815022015

8

Crobeddu ELanzino GKallmes DFCloft HJ: Marked decrease in coil and stent utilization following introduction of flow diversion technology. J Neurointerv Surg 5:3513532013

9

Griessenauer CJOgilvy CSForeman PMChua MHHarrigan MRHe L: Pipeline Embolization Device for small intracranial aneurysms: evaluation of safety and efficacy in a multicenter cohort. Neurosurgery 80:5795872017

10

Hetts SWTurk AEnglish JDDowd CFMocco JPrestigiacomo C: Stent-assisted coiling versus coiling alone in unruptured intracranial aneurysms in the Matrix and Platinum Science Trial: safety, efficacy, and mid-term outcomes. AJNR Am J Neuroradiol 35:6987052014

11

Hong KSSaver JL: Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke 40:382838332009

12

Huhtakangas JLehto HSeppä KKivisaari RNiemelä MHernesniemi J: Long-term excess mortality after aneurysmal subarachnoid hemorrhage: patients with multiple aneurysms at risk. Stroke 46:181318182015

13

Kallmes DFBrinjikji WCekirge SFiorella DHanel RAJabbour P: Safety and efficacy of the Pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies. J Neurosurg 127:7757802017

14

Kallmes DFHanel RLopes DBoccardi EBonafé ACekirge S: International retrospective study of the Pipeline Embolization Device: a multicenter aneurysm treatment study. AJNR Am J Neuroradiol 36:1081152015

15

Le EJMiller TSerulle YShivashankar RJindal GGandhi D: Use of Pipeline Flex is associated with reduced fluoroscopy time, procedure time, and technical failure compared with the first-generation Pipeline embolization device. J Neurointerv Surg [epub ahead of print] 2016

16

Lecler ARaymond JRodriguez-Régent CAl Shareef FTrystram DGodon-Hardy S: Intracranial aneurysms: recurrences more than 10 years after endovascular treatment—a prospective cohort study, systematic review, and meta-analysis. Radiology 277:1731802015

17

Linfante IMayich MSonig AFujimoto JSiddiqui ADabus G: Flow diversion with Pipeline Embolic Device as treatment of subarachnoid hemorrhage secondary to blister aneurysms: dual-center experience and review of the literature. J Neurointerv Surg 9:29332017

18

Malhotra AWu XForman HPGrossetta Nardini HKMatouk CCGandhi D: Growth and rupture risk of small unruptured intracranial aneurysms: a systematic review. Ann Intern Med 167:26332017

19

Martínez-Galdámez MLamin SMLagios KGLiebig TCiceri EFChapot R: Periprocedural outcomes and early safety with the use of the Pipeline Flex Embolization Device with Shield Technology for unruptured intracranial aneurysms: preliminary results from a prospective clinical study. J Neurointerv Surg 9:7727762017

20

Naggara ONLecler AOppenheim CMeder JFRaymond J: Endovascular treatment of intracranial unruptured aneurysms: a systematic review of the literature on safety with emphasis on subgroup analyses. Radiology 263:8288352012

21

Nishido HPiotin MBartolini BPistocchi SRedjem HBlanc R: Analysis of complications and recurrences of aneurysm coiling with special emphasis on the stent-assisted technique. AJNR Am J Neuroradiol 35:3393442014

22

Petr OBrinjikji WCloft HKallmes DFLanzino G: Current trends and results of endovascular treatment of unruptured intracranial aneurysms at a single institution in the flow-diverter era. AJNR Am J Neuroradiol 37:110611132016

23

Phan KHuo YRJia FPhan SRao PJMobbs RJ: Meta-analysis of stent-assisted coiling versus coiling-only for the treatment of intracranial aneurysms. J Clin Neurosci 31:15222016

24

Piotin MBlanc RSpelle LMounayer CPiantino RSchmidt PJ: Stent-assisted coiling of intracranial aneurysms: clinical and angiographic results in 216 consecutive aneurysms. Stroke 41:1101152010

25

Rinkel GJDjibuti MAlgra Avan Gijn J: Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 29:2512561998

26

Saatci IYavuz KOzer CGeyik SCekirge HS: Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results. AJNR Am J Neuroradiol 33:143614462012

27

Sturiale CLBrinjikji WMurad MHLanzino G: Endovascular treatment of intracranial aneurysms in elderly patients: a systematic review and meta-analysis. Stroke 44:189719022013

28

Turk ASJohnston SCHetts SMocco JEnglish JMurayama Y: Geographic differences in endovascular treatment and retreatment of cerebral aneurysms. AJNR Am J Neuroradiol 37:205520592016

29

Wakhloo AKGounis MJ: Revolution in aneurysm treatment: flow diversion to cure aneurysms: a paradigm shift. Neurosurgery 61 (Suppl 1):1111202014

30

Wali ARPark CCSantiago-Dieppa DRVaida FMurphy JDKhalessi AA: Pipeline embolization device versus coiling for the treatment of large and giant unruptured intracranial aneurysms: a cost-effectiveness analysis. Neurosurg Focus 42(6):E62017

31

Zhou GSu MYin YLLi MH: Complications associated with the use of flow-diverting devices for cerebral aneurysms: a systematic review and meta-analysis. Neurosurg Focus 42(6):E172017

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 126 126 126
Full Text Views 71 71 71
PDF Downloads 27 27 27
EPUB Downloads 0 0 0

PubMed

Google Scholar